Stockscreener 앱 받기
20.65
0.24%
0.07
Caredx Inc 주식(CDNA)의 최신 뉴스
CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Yahoo Finance
Can CareDx Inc deliver consistent dividendsDollar Strength & Advanced Swing Trade Entry Alerts - mfd.ru
Death Cross: Is CareDx Inc a play on infrastructure spendingCPI Data & AI Based Buy and Sell Signals - baoquankhu1.vn
CareDx CEO Hanna sells $412,222 in shares By Investing.com - Investing.com Nigeria
CareDx CEO Hanna sells $412,222 in shares - Investing.com
Insider Sell: Hanna John Walter JR Sells Shares of CareDx Inc (C - GuruFocus
CareDx (NASDAQ:CDNA) CEO John Walter Hanna Jr Sells 19,280 Shares - MarketBeat
CareDx, Inc. (CDNA) Stock Analysis: A Healthcare Innovator With 4.66% Upside Potential - DirectorsTalk Interviews
CareDx (NASDAQ:CDNA) CEO John Walter Hanna Jr Sells 10,156 Shares - MarketBeat
Tech Rally: What is the dividend yield of CareDx IncJuly 2025 Analyst Calls & Risk Controlled Swing Alerts - baoquankhu1.vn
Sentiment Review: Can CareDx Inc generate free cash flow2025 Winners & Losers & Community Verified Trade Alerts - baoquankhu1.vn
Sumitomo Mitsui Trust Group Inc. Raises Stock Holdings in CareDx, Inc. $CDNA - MarketBeat
CareDx (CDNA) Is Up 19.5% After Stronger-Than-Expected 2025 Revenue GuidanceHas The Bull Case Changed? - Sahm
CareDx, Inc. (NASDAQ:CDNA) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
CareDx (CDNA) Valuation Check After Strong Preliminary 2025 Revenue Guidance And Transplant+ Pipeline Progress - Sahm
Can CareDx Inc maintain sales growthJuly 2025 Short Interest & Expert Curated Trade Setups - bollywoodhelpline.com
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Vertex Pharmaceuticals (VRTX) and CareDx (CDNA) - The Globe and Mail
Implied Volatility Surging for CareDx Stock Options - sharewise.com
Aug Levels: Is AEYE stock forming a triangle patternRate Hike & Precise Entry and Exit Recommendations - baoquankhu1.vn
CareDx (CDNA) Is Up 9.4% After Strong 2025 Outlook And 10x Genomics Tie-UpHas The Bull Case Changed? - Yahoo Finance
CareDx reports 25% revenue growth in Q4, expects $380 million for 2025 - Investing.com Canada
CareDx (NASDAQ:CDNA) Trading 15.3% HigherTime to Buy? - MarketBeat
Caredx Provides Earnings Guidance Fourth Quarter and Full Year 2025 - marketscreener.com
Aug Wrap: Is CareDx Inc a play on infrastructure spendingStop Loss & Weekly High Return Stock Forecasts - baoquankhu1.vn
CareDx Preliminary Q4 Revenue Up 25% - Nasdaq
CareDx reports 25% revenue growth in Q4, expects $380 million for 2025 By Investing.com - Investing.com South Africa
CareDx's prelim Q4 revenue beats estimates on higher testing volumes - TradingView — Track All Markets
Transplant test maker CareDx reports 25% jump in late‑2025 revenue - Stock Titan
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results - The Joplin Globe
Whittier Daily News - FinancialContent
Profit Review: Can CareDx Inc stock continue upward trendJuly 2025 PostEarnings & Low Risk High Reward Ideas - moha.gov.vn
Why CareDx Inc stock is popular among millennialsGap Down & Verified Chart Pattern Signals - Улправда
Aug Opening: Can CareDx Inc stock continue upward trendJuly 2025 Momentum & Fast Exit/Entry Strategy Plans - Улправда
Can CareDx Inc stock hit record highs again2025 Earnings Surprises & Daily Stock Momentum Reports - Улправда
Dow Update: Will CareDx Inc (1K9) stock gain from lower interest ratesJuly 2025 Macro Moves & AI Enhanced Trading Alerts - Улправда
Why retail investors pile into CareDx Inc stockJuly 2025 Fed Impact & Capital Protection Trade Alerts - Улправда
Why CareDx Inc stock is in analyst buy zoneMarket Activity Summary & Verified Momentum Stock Ideas - ulpravda.ru
CareDx (NASDAQ:CDNA) Trading Down 7.9%What's Next? - MarketBeat
Can CareDx Inc stock continue upward trendShare Buyback & Entry Point Strategy Guides - ulpravda.ru
CareDx and 10x Genomics partner on transplant rejection research By Investing.com - Investing.com Nigeria
CareDx (CDNA) director Michael Goldberg receives 1,492-share equity grant - Stock Titan
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response - BioSpace
Assessing CareDx (CDNA) Valuation After ImmuneScape Multiomics Collaboration With 10x Genomics - Sahm
CareDx, 10x Genomics Establish Multiomics Research Initiative - Contract Pharma
CareDx, 10x Genomics Launch Platform to Study Transplant Rejection and Drug Response - marketscreener.com
CareDx and 10x Genomics partner on transplant rejection research - Investing.com
CareDx, Inc. and 10x Genomics to Launch ImmuneScapeA Multiomics Research Platform to Decode Transplant Rejection and Drug Response - marketscreener.com
User - FinancialContent
CareDx wins preliminary court approval for derivative settlement - MSN
CareDx (NASDAQ:CDNA) Shares Gap DownHere's Why - MarketBeat
Craig-Hallum downgrades CareDx stock rating to Hold from Buy By Investing.com - Investing.com South Africa
IBD rating upgrades: CareDx flashes improved technical strength - MSN
Craig-Hallum downgrades CareDx stock rating to Hold from Buy - Investing.com
Avoiding Lag: Real-Time Signals in (CDNA) Movement - Stock Traders Daily
What drives CareDx Inc 1K9 stock priceFinancial Sector Performance & Low Cost Investment Portfolio - earlytimes.in
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Eagle-Tribune
0.32%
자본화:
|
볼륨(24시간):